Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital

Molecular Cancer Therapeutics, 1535-7163

Journal

  1. 2018
  2. Published

    Acquired Resistance to a MET Antibody Can Be Overcome by the MET Antibody Mixture Sym015

    Pollmann, S. E., Calvert, V. S., Rao, S., Boca, S. M., Madhavan, S., Horak, I. D., Kjaer, A., Petricoin, E. F., Kragh, M. & Poulsen, T. T., Jun 2018, In : Molecular Cancer Therapeutics. 17, 6, p. 1259-1270 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2014
  4. Published

    Proteomics of cancer cell lines resistant to microtubule-stabilizing agents

    Albrethsen, J., Angeletti, R. H., Horwitz, S. B. & Yang, C-P. H., Jan 2014, In : Molecular Cancer Therapeutics. 13, 1, p. 260-9 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. 2010
  6. Published

    A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor

    Olesen, U. H., Thougaard, A. V., Jensen, P. B. & Sehested, M., 1 Jun 2010, In : Molecular Cancer Therapeutics. 9, 6, p. 1609-17 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 110085